Thus, sgG12S and sgG12C were more specific with much lower off-target effects on wild-type KRAS. Next, we confirmed the editing efficiency of sgG12S in A549 lung adenocarcinoma cells harboring the KRAS G12S mutant allele. This evidence concerns the gene KRAS and lung adenocarcinoma.